Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block for Hip Hemiarthroplasty
NCT06369948Completed
- Sponsor
- Fayoum University Hospital
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Total opioid consumption post operative at 48 hours. Started Mar 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06369948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06369948.